Table 2: Liposome-mediated combined chemotherapy.

Combined Chemotherapeutics	Drug delivery system	Type of cancer	Ref.
Fluoroorotic acid and irinotecan	Liposome	Colorectal cancer	[34]
Salinomycin and chloroquine	Liposome	Human hepatoma carcinoma	[35]
Salinomycin and Doxorubicin	Liposome	Human hepatoma carcinoma	[36]
Doxorubicin and erlotinib	Liposome	Triple negative breast cancer, Non-small cell lung cancer	[37]
Omacetaxine Mepesuccinate and doxorubicin	Liposome	Human cervical carcinoma	[38]
Combretastatin A-4 and doxorubicin	Octreotide-modified stealth liposomes	Non-small cell lung cancer, Breast cancer	[39]
Paclitaxel and doxorubicin	Liposome	Lung cancer	[40]
Paclitaxel and lonidamine	Liposome	Breast cancer	[41]
Topotecan and vincristine	Liposome	Daoy tumors	[42]
Vincristine and quercetin	Liposome	Breast tumor	[43]
Vincristine and temozolomide	Solid lipid nanoparticles	Glioma	[44]